Christopher S. Konkoy

1.1k total citations
23 papers, 888 citations indexed

About

Christopher S. Konkoy is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Christopher S. Konkoy has authored 23 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Christopher S. Konkoy's work include Neuroscience and Neuropharmacology Research (9 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (7 papers). Christopher S. Konkoy is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (7 papers). Christopher S. Konkoy collaborates with scholars based in United States, Sweden and Mexico. Christopher S. Konkoy's co-authors include Thomas P. Davis, Steven R. Childers, Richard M. Woodward, Edward R. Whittemore, Matthias Herz, Meng H. Tan, Don Johns, Lawrence D. Wise, Peter A. Boxer and Leonard T. Meltzer and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Christopher S. Konkoy

23 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher S. Konkoy United States	16	386	260	246	170	133	23	888
Dac M. Dinh United States	17	489 1.3×	113 0.4×	344 1.4×	144 0.8×	101 0.8×	29	1.1k
Philip A. Carpino United States	20	414 1.1×	122 0.5×	123 0.5×	365 2.1×	143 1.1×	42	1.1k
Teisuke Takahashi Japan	12	283 0.7×	68 0.3×	269 1.1×	60 0.4×	157 1.2×	35	658
George Gessner United States	17	506 1.3×	222 0.9×	56 0.2×	173 1.0×	126 0.9×	41	916
Catherine Cazaubon France	15	389 1.0×	65 0.3×	219 0.9×	105 0.6×	466 3.5×	35	869
Marco Criscuoli Italy	18	419 1.1×	371 1.4×	55 0.2×	79 0.5×	121 0.9×	76	1.0k
Dung Thai United States	15	218 0.6×	94 0.4×	157 0.6×	80 0.5×	48 0.4×	35	708
Marie Claude Fournié-Zaluski France	12	375 1.0×	397 1.5×	162 0.7×	74 0.4×	245 1.8×	16	765
Magdi M. Asaad United States	21	411 1.1×	189 0.7×	185 0.8×	200 1.2×	499 3.8×	45	1.1k
Masaya Fukuda Japan	16	229 0.6×	121 0.5×	130 0.5×	38 0.2×	238 1.8×	21	802

Countries citing papers authored by Christopher S. Konkoy

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Konkoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Konkoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Konkoy more than expected).

Fields of papers citing papers by Christopher S. Konkoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Konkoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Konkoy. The network helps show where Christopher S. Konkoy may publish in the future.

Co-authorship network of co-authors of Christopher S. Konkoy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Konkoy. A scholar is included among the top collaborators of Christopher S. Konkoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Konkoy. Christopher S. Konkoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suico, Jeffrey G., Stuart Friedrich, Ellen A. Cannady, et al.. (2014). Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults. Journal of Pharmacy and Pharmacology. 66(11). 1576–1585. 31 indexed citations

Small, David S., Nagy A. Farid, Christopher D. Payne, et al.. (2010). Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel. Clinical Pharmacokinetics. 49(12). 777–798. 46 indexed citations

Farid, Nagy A., David S. Small, Christopher D. Payne, et al.. (2008). Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(12). 1483–1493. 73 indexed citations

Garg, Satish K., Julio Rosenstock, Bernard L. Silverman, et al.. (2006). Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia. 49(5). 891–899. 55 indexed citations

Tan, Meng H., Don Johns, Guillermo González-Gálvez, et al.. (2004). Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial. Clinical Therapeutics. 26(5). 680–693. 51 indexed citations

Tan, Meng H., Don Johns, Jorma Strand, et al.. (2004). Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabetic Medicine. 21(8). 859–866. 58 indexed citations

Herz, Matthias, Don Johns, Jesús Reviriego, et al.. (2003). A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. Clinical Therapeutics. 25(4). 1074–1095. 114 indexed citations

Wright, Jonathan L., Tracy F. Gregory, Suzanne R. Kesten, et al.. (2000). Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 43(18). 3408–3419. 95 indexed citations

Gregory, Tracy F., Jon L. Wright, Lawrence D. Wise, et al.. (2000). Parallel synthesis of a series of subtype-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(6). 527–529. 8 indexed citations

10.

Wright, Jon L., Tracy F. Gregory, Christopher F. Bigge, et al.. (1999). Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines. Journal of Medicinal Chemistry. 42(13). 2469–2477. 85 indexed citations

11.

Wright, Jon L., Tracy F. Gregory, Peter A. Boxer, et al.. (1999). Discovery of subtype-selective NMDA receptor ligands: 4-Benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1a/2B antagonists. Bioorganic & Medicinal Chemistry Letters. 9(19). 2815–2818. 15 indexed citations

12.

Wang, Yan, Christopher S. Konkoy, Victor I. Ilyin, et al.. (1998). Synthesis of 7,8-(Methylenedioxy)-1-phenyl-3,5-dihydro-4H-2,3-benzodiazepin- 4-ones as Novel and Potent Noncompetitive AMPA Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2621–2625. 20 indexed citations

13.

Whittemore, Edward R., Victor I. Ilyin, Christopher S. Konkoy, & Richard M. Woodward. (1997). Subtype-selective antagonism of NMDA receptors by nylidrin. European Journal of Pharmacology. 337(2-3). 197–208. 24 indexed citations

14.

Konkoy, Christopher S. & Thomas P. Davis. (1996). Ectoenzymes as sites of peptide regulation. Trends in Pharmacological Sciences. 17(8). 288–294. 49 indexed citations

15.

Konkoy, Christopher S., Stephen M. Waters, & Thomas P. Davis. (1996). Subchronic haloperidol administration decreases aminopeptidase N activity and [Met5]enkephalin metabolism in rat striatum and cortex. European Journal of Pharmacology. 297(1-2). 47–51. 10 indexed citations

16.

Waters, Stephen M., Christopher S. Konkoy, & Thomas P. Davis. (1995). Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 783–789. 12 indexed citations

17.

Konkoy, Christopher S. & Thomas P. Davis. (1995). Regional Metabolism of Met‐Enkephalin and Cholecystokinin on Intact Rat Brain Slices: Characterization of Specific Peptidases. Journal of Neurochemistry. 65(6). 2773–2782. 14 indexed citations

18.

Konkoy, Christopher S., Stephen M. Waters, & Thomas P. Davis. (1994). Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.. Journal of Pharmacology and Experimental Therapeutics. 269(2). 555–563. 13 indexed citations

19.

Konkoy, Christopher S. & Steven R. Childers. (1993). Relationship between kappa1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes. Biochemical Pharmacology. 45(1). 207–216. 25 indexed citations

20.

Konkoy, Christopher S., et al.. (1993). Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions. Peptides. 14(5). 1017–1020. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact